Boston, June 8, 2020 - Proskauer, a leading international law firm, announced that it advised Atlas Venture on the formation of Atlas Venture Fund XII.
The fund was oversubscribed and closed at its hard cap of $400 million in commitments. Atlas Venture is a Cambridge, Massachusetts-based early stage venture capital firm that has been building and investing in innovative biotechnology startups for more than two decades. Since 2017, Atlas has raised $1 billion across three funds committed to delivering high-impact therapies to patients.
Proskauer offers a full suite of services for the investment management industry, with a market-leading global team dedicated solely to advising asset managers, investment funds and their advisers, financial institutions and institutional investors across the asset class. The cross border team of over 150 lawyers is based in the U.S., UK, Asia and Latin America and includes specialists in tax, ERISA, regulation, financial services, employment, insurance, fund finance, litigation and risk management who understand the unique technical and commercial issues relevant to investment managers.